Various studies have shown associations between obesity and an increased risk of breast cancer among postmenopausal non-users of HT, particularly of ER+ / PR+ breast cancer, but not ER- / PR- breast cancer [4, 22, 23]. The gene discussed is ESR1; the disease is breast carcinoma.